Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRx0014 continuation in Alzheimer's
NCT00684944Phase 2Completed
- Sponsor
- TauRx Therapeutics Ltd
- Start
- Sep 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of methylene blue in Alzheimer's disease (AD), sponsored by TauRx Therapeutics Ltd. Started Sep 2007; status: completed.
02
Drugs
methylene blue
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00684944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684944.